Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Key Studies on Vaccine-Preventable Diseases Influencing My Practice Following IDWeek 2021—Audio Recap

September 29 - October 3, 2021; Virtual
Listen to expert insights from Martin C. Mahoney, MD, PhD, on new data for vaccine-preventable diseases presented at the IDWeek meeting, including pneumococcal disease, respiratory syncytial virus, herpes zoster, and influenza.
Martin C. Mahoney, MD, PhD
Released: December 6, 2021

In this episode, Martin C. Mahoney, MD, PhD, discusses new data on vaccine-preventable diseases from IDWeek 2021, including:

  • Pneumococcal disease
  • Respiratory syncytial virus (RSV)
  • Herpes zoster
  • Influenza

Information on this Educational Activity

Faculty

Martin C. Mahoney, MD, PhD

Professor of Oncology
Department of Internal Medicine
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Martin C. Mahoney, MD, PhD, has disclosed that he has received consulting fees from Merck, Pfizer, and Sanofi; fees for non-CME/CE services from GlaxoSmithKline, Merck, Pfizer, and Sanofi; and other financial or material support from Pfizer.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.

Related Content

Expert commentary on the use of diabetes technologies in pediatric patients, from Jennifer Sherr, MD, PhD, and Clinical Care Options (CCO)

Jennifer Sherr, MD, PhD Released: January 14, 2022

Clinical Care Options (CCO): Dr. Paul Auwaerter discusses the latest pneumococcal vaccine data and the impact on his practice, presented at IDWeek 2021

Paul G. Auwaerter, MD Released: November 19, 2021

Expert IDWeek 2021 video: vaccines for pneumococcal disease, respiratory syncytial virus, herpes zoster, and influenza, from CCO

Martin C. Mahoney, MD, PhD Released: November 11, 2021

Expert selections of important new vaccine data from IDWeek 2021 including vaccines for pneumococcal disease, respiratory syncytial virus vaccine, herpes zoster, influenza from Clinical Care Options (CCO)

Martin C. Mahoney, MD, PhD Released: November 3, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings